Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ACOGAlpha Cognition Inc.

Nasdaq · CIK 0001655923
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts258

Identity from submissions API

NameAlpha Cognition Inc.
CIK0001655923
TickersACOG
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationA1 British Columbia, Canada
Phone(858) 344-4375
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Neurodyn Cognition Inc. (2015-10-16T04:00:00.000Z → 2019-10-09T04:00:00.000Z)
Business address
1452 HUGHES RD., STE. 200
GRAPEVINE
TX
76051
TX
Mailing address
1452 HUGHES RD., STE. 200
GRAPEVINE
TX
76051
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

221 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001604867-26-000019 005-94748 261557342 34 76320
2026-11-13 4 FORM 4 0000912282-26-001491 6848
2026-11-13 3 FORM 3 0000912282-26-001489 3250
2026-11-12 8-K CURRENT REPORT 5.02,9.01 0001213900-26-118958 001-42403 261547304 34 200550 1 1
2026-11-12 10-Q QUARTERLY REPORT 0001213900-26-118702 001-42403 261545174 34 6531767 1 1
2026-10-26 4 4 0001493152-26-048562 9589
2026-10-19 4 4 0001493152-26-047631 9589
2026-10-02 4 4 0001493152-26-045511 7443
2026-09-28 4 4 0001493152-26-044690 9146
2026-09-23 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-006448 005-94748 261401829 34 21136
2026-09-16 4 4 0001493152-26-042969 13423
2026-08-24 4 FORM 4 0000912282-26-001153 4685
2026-08-13 10-Q QUARTERLY REPORT 0001213900-26-089188 001-42403 261274517 34 5696700 1 1
2026-08-04 4 4 0001493152-26-036015 9129
2026-07-28 4 4 0001493152-26-035000 6981
2026-07-24 4 4 0001493152-26-034560 10532
2026-07-24 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-034562 005-94748 261201518 34 23393
2026-06-29 4 4 0001493152-26-031063 9129
2026-06-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-031066 005-94748 261135703 34 23227
2026-06-23 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-26-070903 001-42403 261109506 34 205066 1 1
2026-06-15 4 4 0001493152-26-028783 11719
2026-06-11 4 4 0001493152-26-028276 9574
2026-06-09 4 4 0001493152-26-027927 7425
2026-05-29 4 4 0001493152-26-026472 11273
2026-05-22 4 4 0001493152-26-025011 8685
2026-05-22 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-025014 005-94748 261013653 34 23302
2026-05-19 4 FORM 4 0000912282-26-000743 4781
2026-05-19 4 4 0001493152-26-024411 9571
2026-05-14 10-Q QUARTERLY REPORT 0001213900-26-056588 001-42403 26978587 34 4835044 1 1
2026-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002904 005-94748 26970341 34 17856
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-022232 005-94748 26963464 34 23016
2026-05-01 8-K/A FORM 8-K/A 5.02,9.01 0001213900-26-050998 001-42403 26933359 34 195443 1 1
2026-04-30 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-050236 001-42403 26925495 34 799274
2026-04-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-050234 001-42403 26925478 34 7901654 1 1
2026-04-20 8-K FORM 8-K 5.02,9.01 0001213900-26-045668 001-42403 26875806 34 196024 1 1
2026-04-17 4 FORM 4 0000912282-26-000624 6854
2026-04-17 3 FORM 3 0000912282-26-000622 3137
2026-04-14 8-K CURRENT REPORT 1.01,9.01 0001213900-26-043517 001-42403 26860808 34 285458 1 1
2026-03-31 10-K ANNUAL REPORT 0001213900-26-037614 001-42403 26823270 34 13061500 1 1
2026-03-31 4 xslF345X06/ownership.xml 0001493152-26-014123 9118
2026-03-27 8-K CURRENT REPORT 7.01,9.01 0001213900-26-035696 001-42403 26808530 34 211486 1 1
2026-03-26 4 4 0001493152-26-013022 11275
2026-03-26 8-K CURRENT REPORT 2.02,9.01 0001213900-26-034778 001-42403 26798882 34 377205 1 1
2026-03-20 4 4 0001493152-26-011902 9498
2026-03-18 4 xslF345X06/ownership.xml 0001493152-26-011391 7336
2026-03-13 4 4 0001493152-26-010130 9433
2026-03-10 4 4 0001493152-26-009591 9433
2026-03-06 4 4 0001493152-26-009136 10390
2026-03-04 4 4 0001493152-26-008846 9945
2026-03-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-008847 005-94748 26721146 34 23106
2026-03-02 4 4 0001493152-26-008538 9432
2026-02-24 4 4 0001493152-26-007920 16030
2026-02-23 8-K CURRENT REPORT 5.02 0001213900-26-019355 001-42403 26665711 34 190731 1 1
2026-02-20 3/A 3/A 0001493152-26-007654 5869
2026-02-20 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-007652 005-94748 26661877 34 23030
2026-02-20 3 3 0001493152-26-007594 6054
2026-02-20 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-007593 005-94748 26659961 34 23069
2026-02-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002073679-26-000042 005-94748 26655879 34 99004
2026-02-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002073679-26-000040 005-94748 26650557 34 10590
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-055106 005-94748 26643532 34 12256
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-001080 005-94748 26638232 34 13296
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001535264-26-000009 005-94748 26631329 34 10379
2026-02-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-005553 005-94748 26607569 34 22540
2026-01-16 4 FORM 4 0000912282-26-000072 7820
2026-01-16 4 FORM 4 0000912282-26-000070 6710
2026-01-16 4 FORM 4 0000912282-26-000067 7433
2026-01-16 4 FORM 4 0000912282-26-000065 8593
2026-01-16 4 FORM 4 0000912282-26-000063 7458
2026-01-15 8-K FORM 8-K 5.02,9.01 0001213900-26-004765 001-42403 26537099 34 193845 1 1
2026-01-13 4 FORM 4 0000912282-26-000037 10282
2026-01-13 4 FORM 4 0000912282-26-000035 6989
2026-01-13 4 FORM 4 0000912282-26-000033 7011
2026-01-13 S-8 REGISTRATION STATEMENT 0001213900-26-003651 333-292687 26528356 33 290825 1 1
2025-11-13 10-Q QUARTERLY REPORT 0001213900-25-110061 001-42403 251479284 34 4952133 1 1
2025-10-15 8-K/A AMENDMENT TO FORM 8-K 4.01,9.01 0001213900-25-098886 001-42403 251392858 34 202425 1 1
2025-10-14 8-K CURRENT REPORT 4.01,9.01 0001213900-25-098739 001-42403 251391841 34 291001 1 1
2025-10-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-016845 005-94748 251373746 34 22989
2025-10-02 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-094911 001-42403 251366408 34 802827 1 1
2025-10-01 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-094786 333-289792 251365678 33 560002
2025-09-30 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-094024 333-289792 251361218 33 564346
2025-08-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002794 333-289792 251282763 33 1928
2025-08-29 424B2 PROSPECTUS SUPPLEMENT 0001213900-25-082652 333-289792 251281702 33 474403
2025-08-29 424B3 PROSPECTUS 0001213900-25-082649 333-289792 251281675 33 276139
2025-08-28 CORRESP filename1.htm 0001213900-25-081510 6066
2025-08-28 UPLOAD filename1.pdf 0000000000-25-009243 333-289792 40266
2025-08-22 8-K FORM 8-K 1.01,9.01 0001213900-25-080012 001-42403 251247270 34 196602 1 1
2025-08-22 S-3 REGISTRATION STATEMENT 0001213900-25-079892 333-289792 251246208 33 1745472 1 1
2025-08-21 4 xslF345X05/form4.xml 0000912282-25-000893 4961
2025-08-20 4 xslF345X05/form4.xml 0000912282-25-000891 5439
2025-08-20 4 xslF345X05/form4.xml 0000912282-25-000889 5018
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076600 001-42403 251218546 34 6387820 1 1
2025-08-05 424B3 PROSPECTUS 0001213900-25-071680 333-288823 251182381 33 323049
2025-07-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002363 333-288823 251152836 33 1826
2025-07-23 CORRESP filename1.htm 0001213900-25-067011 6518
2025-07-23 UPLOAD filename1.pdf 0000000000-25-007756 333-288823 40197
2025-07-21 S-3 REGISTRATION STATEMENT 0001213900-25-066219 333-288823 251138134 33 487102
2025-07-17 424B3 PROSPECTUS 0001213900-25-065096 333-288454 251130271 33 509692
2025-07-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002195 333-288454 251112199 33 1826
2025-07-03 CORRESP filename1.htm 0001213900-25-061538 6002
2025-07-03 UPLOAD filename1.pdf 0000000000-25-007056 333-288454 40158
2025-07-01 S-3 REGISTRATION STATEMENT 0001213900-25-060388 333-288454 251096784 33 710013
2025-06-23 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-25-056752 001-42403 251065620 34 206681 1 1
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044163 001-42403 25952431 34 6701742 1 1
2025-05-06 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-039816 001-42403 25914565 34 1652438
2025-05-06 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-039815 001-42403 25914562 34 621126
2025-04-30 DEF 14A PROXY STATEMENT 0001213900-25-037661 001-42403 25895961 34 9190895 1 1
2025-04-29 4 xslF345X05/form4.xml 0000912282-25-000479 5073
2025-04-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001699575-25-000004 005-94748 25842383 34 13589
2025-04-10 8-K FORM 8-K 5.02,9.01 0001213900-25-030683 001-42403 25828923 34 203075 1 1
2025-04-09 4 xslF345X05/form4.xml 0000912282-25-000390 5044
2025-04-09 3 xslF345X02/form3.xml 0000912282-25-000389 2792
2025-03-31 10-K ANNUAL REPORT 0001213900-25-026225 001-42403 25793026 34 10811609 1 1
2025-02-27 4 xslF345X05/form4.xml 0000912282-25-000204 5086
2025-02-27 4 xslF345X05/form4.xml 0000912282-25-000203 5078
2025-02-27 4 xslF345X05/form4.xml 0000912282-25-000202 5078
2025-02-27 4 xslF345X05/form4.xml 0000912282-25-000201 5076
2025-02-27 4 xslF345X05/form4.xml 0000912282-25-000200 5167
2025-02-27 4 xslF345X05/form4.xml 0000912282-25-000199 5257
2025-02-27 8-K CURRENT REPORT 5.02,9.01 0001213900-25-018138 001-42403 25680457 34 230420 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020829 005-94748 25626032 34 174546
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001604867-25-000003 005-94748 25625930 34 76153
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001535264-25-000010 005-94748 25619897 34 8930
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001535264-25-000009 005-94748 25619830 34 9312
2025-01-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-000782 005-94748 25579859 34 12819
2025-01-15 424B3 PROSPECTUS 0001213900-25-003648 333-278997 25531315 33 15854493
2025-01-15 424B3 PROSPECTUS 0001213900-25-003646 333-284104 25531303 33 15199897
2025-01-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000093 333-284104 25527582 33 1832
2025-01-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000085 333-278997 25527574 33 1845
2025-01-10 CORRESP filename1.htm 0001213900-25-002406 6329
2025-01-10 CORRESP filename1.htm 0001213900-25-002291 8013
2025-01-10 POS AM POST-EFFECTIVE AMENDMENT 0001213900-25-002286 333-278997 25520213 33 37725083 1 1
2025-01-10 S-1/A REGISTRATION STATEMENT 0001213900-25-002277 333-284104 25520168 33 36968248 1 1
2025-01-03 UPLOAD filename1.pdf 0000000000-25-000065 333-284104 40166
2024-12-31 POS AM POST-EFFECTIVE AMENDMENT 0001213900-24-114085 333-278997 241593664 33 37928397 1 1
2024-12-31 S-1 REGISTRATION STATEMENT 0001213900-24-114064 333-284104 241593563 33 37078832 1 1
2024-12-31 S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 0001213900-24-113984 333-282666 241593143 33 93579
2024-12-20 8-K CURRENT REPORT 3.02,9.01 0001213900-24-111194 001-42403 241568187 34 198357 1 1
2024-11-18 8-K CURRENT REPORT 1.01,3.02,3.03,9.01 0001213900-24-099596 001-42403 241471222 34 694772 1 1
2024-11-18 D xslFormDX01/primary_doc.xml 06b 0001727689-24-000137 021-529724 241471086 33 11368
2024-11-15 SC 13D/A havens13da.htm 0000912282-24-000815 005-94748 241468766 34 30155
2024-11-15 SC 13D havens13d.htm 0000912282-24-000813 005-94748 241468650 34 54861
2024-11-15 4 xslF345X05/form4.xml 0000912282-24-000811 4549
2024-11-15 4 xslF345X05/form4.xml 0000912282-24-000808 4953
2024-11-15 4 xslF345X05/form4.xml 0000912282-24-000806 6761
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098409 001-42403 241461911 34 8550938 1 1
2024-11-13 3 xslF345X02/form3.xml 0000912282-24-000800 4281
2024-11-13 424B4 PROSPECTUS 0001213900-24-097035 333-280196 241451037 33 14979246
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000791 10854
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000789 9262
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000787 7565
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000785 9679
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000782 6733
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000780 13458
2024-11-12 3 xslF345X02/form3.xml 0000912282-24-000778 8447
2024-11-12 CERT ACOG_8-ACert.pdf 0001354457-24-000859 001-42403 241444497 34 219680
2024-11-12 S-1MEF REGISTRATION STATEMENT 0001213900-24-096308 333-283126 241443978 33 88894
2024-11-12 POS EX POST-EFFECTIVE AMENDMENT 0001213900-24-096295 333-280196 241443902 33 117201
2024-11-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-11-08 17:00:00 9999999995-24-003416 333-280196 241442668 33 1833
2024-11-08 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-24-095780 001-42403 241439404 34 14271
2024-11-06 CORRESP filename1.htm 0001213900-24-095031 10649
2024-11-06 CORRESP filename1.htm 0001213900-24-095026 5493
2024-11-06 S-1/A REGISTRATION STATEMENT 0001213900-24-094839 333-280196 241429670 33 35492207 1 1
2024-11-05 8-K CURRENT REPORT 3.03,9.01 0001213900-24-094626 333-278997 241428482 34 198376 1 1
2024-10-25 CORRESP filename1.htm 0001213900-24-090889 12732
2024-10-25 S-1/A REGISTRATION STATEMENT 0001213900-24-090875 333-280196 241397941 33 35777803 1 1
2024-10-25 424B3 PROSPECTUS 0001213900-24-090746 333-282675 241396826 33 14820482
2024-10-24 8-K CURRENT REPORT 5.02,9.01 0001213900-24-090112 333-278997 241390579 34 196044 1 1
2024-10-23 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-10-23 16:00:00 9999999995-24-003253 333-282675 241390449 33 1833
2024-10-23 UPLOAD filename1.pdf 0000000000-24-011845 377-07258 46830
2024-10-21 CORRESP filename1.htm 0001213900-24-089373 6425
2024-10-21 UPLOAD filename1.pdf 0000000000-24-011771 333-282675 40107
2024-10-16 S-1 REGISTRATION STATEMENT 0001213900-24-088116 333-282675 241374200 33 35009594 1 1
2024-10-16 S-1/A REGISTRATION STATEMENT 0001213900-24-088111 333-280196 241374193 33 35403192 1 1
2024-10-16 S-8 REGISTRATION STATEMENT 0001213900-24-087958 333-282666 241373244 33 161745
2024-10-09 D xslFormDX01/primary_doc.xml 06b 0000912282-24-000697 021-526363 241363207 33 13256
2024-10-09 8-K FORM 8-K 5.02,9.01 0001213900-24-086624 333-278997 241362944 34 193661 1 1
2024-10-03 8-K CURRENT REPORT 5.03,5.07,9.01 0001213900-24-085098 333-278997 241352373 34 704251 1 1
2024-09-26 8-K/A CURRENT REPORT 9.01 0001213900-24-081881 333-278997 241325744 34 631305 1 1
2024-09-25 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-24-081586 333-278997 241321367 34 1461363 1 1
2024-08-28 8-K CURRENT REPORT 8.01,9.01 0001213900-24-073262 333-278997 241253719 34 2049057 1 1
2024-08-27 8-K FORM 8-K 5.02 0001213900-24-072967 333-278997 241248912 34 188180 1 1
2024-08-15 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-069523 333-278997 241211583 33 1410899
2024-08-13 8-K CURRENT REPORT 2.02,9.01 0001213900-24-067814 333-278997 241198253 34 265079 1 1
2024-08-12 10-Q QUARTERLY REPORT 0001213900-24-067658 333-278997 241196740 34 8802208 1 1
2024-08-09 8-K CURRENT REPORT 3.03 0001213900-24-067133 333-278997 241192583 34 192220 1 1
2024-07-30 S-1/A REGISTRATION STATEMENT 0001013762-24-002238 333-280196 241154251 33 14727800
2024-07-29 8-K CURRENT REPORT 7.01,9.01 0001013762-24-002122 333-278997 241152952 34 263736 1 1
2024-06-14 8-K CURRENT REPORT 1.01,9.01 0001213900-24-052933 333-278997 241046093 34 28179
2024-06-14 S-1 REGISTRATION STATEMENT 0001213900-24-052607 333-280196 241042914 33 14647873
2024-06-10 424B3 PROSPECTUS 0001213900-24-051296 333-278997 241033505 33 14188023
2024-06-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-06-07 16:00:00 9999999995-24-001784 333-278997 241031382 33 1833
2024-06-06 CORRESP filename1.htm 0001213900-24-050283 6909
2024-06-04 DRS filename1.htm 0001213900-24-049510 377-07258 241016977 33 13871309
2024-06-04 S-1/A REGISTRATION STATEMENT 0001213900-24-049203 333-278997 241015541 33 14473969
2024-05-22 CORRESP filename1.htm 0001213900-24-045925 14998
2024-05-22 S-1/A REGISTRATION STATEMENT 0001213900-24-045921 333-278997 24973660 33 14503662
2024-05-21 UPLOAD filename1.pdf 0000000000-24-005884 377-07090 46062
2024-05-10 CORRESP filename1.htm 0001213900-24-041784 66914
2024-05-10 S-1/A REGISTRATION STATEMENT 0001213900-24-041780 333-278997 24935730 33 11525590
2024-05-08 UPLOAD filename1.pdf 0000000000-24-005215 377-07090 74164
2024-04-30 S-1 REGISTRATION STATEMENT 0001213900-24-037413 333-278997 24894591 33 36236472
2024-04-23 DRSLTR filename1.htm 0001213900-24-035144 206197
2024-04-23 DRS/A filename1.htm 0001213900-24-035141 377-07090 24862839 33 11497282
2024-04-17 UPLOAD filename1.pdf 0000000000-24-004171 377-07090 115359
2024-03-21 DRS/A filename1.htm 0001213900-24-024477 377-07090 24769223 33 15168888
2024-02-09 DRS filename1.htm 0001213900-24-011894 377-07090 24612856 33 39824566
2024-01-31 D xslFormDX01/primary_doc.xml 06b 0001727689-24-000014 021-504048 24582565 33 14994
2024-01-05 D xslFormDX01/primary_doc.xml 06b 0001727689-24-000004 021-501751 24516570 33 14008
2023-11-20 D xslFormDX01/primary_doc.xml 06b 0001727689-23-000093 021-497665 231421177 33 13133
2023-10-19 D xslFormDX01/primary_doc.xml 06b 0001727689-23-000082 021-495209 231334565 33 12950
2023-09-12 D xslFormDX01/primary_doc.xml 06b 0001727689-23-000069 021-491869 231249399 33 13787
2023-03-28 D xslFormDX01/primary_doc.xml 06b 0001727689-23-000019 021-477050 23765917 33 13846
2023-02-28 D xslFormDX01/primary_doc.xml 06b 0001727689-23-000010 021-474403 23677351 33 12155
2021-10-18 D xslFormDX01/primary_doc.xml 06b 0001655923-21-000001 021-417286 211326890 33 13633
2020-12-28 D xslFormDX01/primary_doc.xml 06b 0001655923-20-000004 021-384386 201416413 33 10248
2020-05-01 D xslFormDX01/primary_doc.xml 06b 0001655923-20-000003 021-366136 20839416 33 10075
2019-10-09 D xslFormDX01/primary_doc.xml 06b 0001655923-19-000003 021-350728 191144697 33 8949
2018-07-20 D xslFormDX01/primary_doc.xml 06b 0001140361-18-033048 021-317450 18963077 33 7277
2017-12-19 D xslFormDX01/primary_doc.xml 06b 0001140361-17-046687 021-301140 171263702 33 7743
2016-04-26 D xslFormDX01/primary_doc.xml 06b 0001140361-16-062059 021-262043 161591394 33 7806
2015-10-16 D xslFormDX01/primary_doc.xml 06b 0001140361-15-037869 021-249585-01 151162346 33 13654

Latest XBRL company facts

One latest value per concept from companyfacts (258 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 22.04M 2026-11-11 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
dei EntityPublicFloat Entity Public Float USD 149.50M 2025-06-30 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 7.87M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 659,568 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 826,055 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 6.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -64,101 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap AccretionExpense Accretion Expense USD 4,894 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 450,321 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 2.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties EUR 5.21M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 13,889 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -104,301 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 32.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AdjustmentForAmortization Amortization USD 57,496 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 979,799 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 89,631 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 5.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap AdvancesToAffiliate Advances to Affiliate USD 55,000 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap AdvertisingExpense Advertising Expense USD 380,774 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD -331,458 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 64,101 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 459,360 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 167,614 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred EUR 3.00M 2016-01-01 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap Assets Assets USD 64.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap AssetsCurrent Assets, Current USD 57.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap Cash Cash USD 53,909 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 37.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 37.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 48.56M 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -28.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 47.07M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 10.55 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 2.42M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 215,421 2024-11-13 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 2.18M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089188
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 6,600 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap CommonStockConvertibleConversionPriceDecrease Common Stock, Convertible, Conversion Price, Decrease USD/shares 7.19 2024-11-13 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap CommonStockConvertibleConversionPriceIncrease Common Stock, Convertible, Conversion Price, Increase USD/shares 5.75 2024-11-13 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.01 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067658
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 21.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 21.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap CommonStockValue Common Stock, Value, Issued USD 136.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -14.64M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ContractualObligation Contractual Obligation USD 3.35M 2024-12-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 91,234 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 15,085 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 55,825 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 801,413 2024-11-13 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 801,412 2024-11-13 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ConvertibleDebt Convertible Debt USD 2.42M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 1.00M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization USD 248,853 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056588
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 603,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap CostOfRevenue Cost of Revenue USD 1.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap CostsAndExpenses Costs and Expenses USD 11.63M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056588
us-gaap DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 Debt Instrument, Convertible, Threshold Consecutive Trading Days pure 10 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 4,195 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 153,171 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredIncomeNoncurrent Deferred Income, Noncurrent USD 35,944 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 202,675 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 223,096 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 1.57M 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 195,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 19.89M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 11.00M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1,000 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 333,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 19.89M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 3,000 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DepositAssets Deposit Assets USD 39.41M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap Depreciation Depreciation USD 1,895 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 253,885 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 892,745 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 88,155 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 523,491 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap DerivativeLiabilities Derivative Liability USD 2.35M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 4.81M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 2,450 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.287 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.117 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.092 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.067 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.092 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.067 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -19,573 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.87M 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 275,154 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 582,245 2024-01-01 2024-01-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap FairValueConcentrationOfRiskForeignCurrencyContracts Fair Value, Concentration of Risk, Foreign Currency Contracts CAD 154,000 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap FeeIncome FeeIncome USD 7,500 2022-08-15 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap FinancialInstrumentsOwnedOtherAtFairValue Financial Instruments, Owned, Other, at Fair Value USD 440,046 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 961,824 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 351,991 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 87,996 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 21,546 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056588
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 351,991 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 351,991 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 351,991 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 7.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 6.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ForeignCurrencyContractsLiabilityFairValueDisclosure Foreign Currency Contracts, Liability, Fair Value Disclosure EUR 2.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -48,157 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -18,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -18,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.94M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap GovernmentAssistanceNonoperatingIncome GovernmentAssistanceNonoperatingIncome USD 71,095 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089188
us-gaap GovernmentAssistanceOperatingExpense GovernmentAssistanceOperatingExpense USD -53,051 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap GrossProfit Gross Profit USD 16.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 39,166 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 39,166 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -20.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -9.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -11.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 2.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -65,996 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -82,796 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 418,275 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 1.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 407,582 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 65,996 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 8,163 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 4,894 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 2.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap InventoryNet Inventory, Net USD 6.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 4.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 229,208 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap InvestmentCompanyIncreaseDecreaseFromShareTransaction InvestmentCompanyIncreaseDecreaseFromShareTransaction USD 4.54M 2023-08-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 71,095 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 2.27M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap LegalFees Legal Fees USD 14,575 2024-01-01 2024-01-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap Liabilities Liabilities USD 14.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 64.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 47,333 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -6.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -23.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -21.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -15.63M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089188
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -20.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -22.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NoncurrentAssets Long-Lived Assets USD 719,963 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -601,547 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NotesIssued1 Notes Issued USD 3.07M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap NotesPayable Notes Payable USD 911,463 2024-12-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap NotesPayableCurrent Notes Payable, Current USD 300,000 2024-04-01 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OperatingExpenses Operating Expenses USD 37.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -21.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 486,663 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 45,714 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -19,573 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD 10,700 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -19,573 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap OtherExpenses Other Expenses USD 72,004 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap OtherLiabilities Other Liabilities USD 82,819 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 79,846 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 23,739 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 11,919 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056588
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 15,414 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OtherNotesPayable Other Notes Payable USD 2.00M 2020-11-30 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2,014 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap OtherReceivablesGrossCurrent Other Receivables, Gross, Current USD 185,707 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 136,986 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap PaymentForManagementFee Payment for Management Fee USD 13,333 2018-09-01 2018-09-30 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap PaymentsForCommissions Payments for Commissions USD 391,178 2024-01-01 2024-01-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap PaymentsForFees Payments for Other Fees USD 320,000 2024-01-19 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap PaymentsForPurchaseOfOtherAssets1 Payments for Purchase of Other Assets USD 50,000 2020-11-01 2020-11-30 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 459,360 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 50,000 2020-11-01 2020-11-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 5.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 281,986 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 62 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 971,534 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 80,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap PrepaidInsurance Prepaid Insurance USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap PrincipalAmountOutstandingOnLoansSecuritized Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement USD 55,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 4.54M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 104,569 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 3.73M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 160,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 34.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 1,800 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 2.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.40M 2015-03-01 2015-03-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 417,064 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ProductWarrantyLiquidationProceedsPercentage ProductWarrantyLiquidationProceedsPercentage pure 0.1 2023-05-30 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 84,341 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 524,255 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ProvisionForLoanLeaseAndOtherLosses Provision for Loan, Lease, and Other Losses USD 55,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ProvisionForOtherLosses Provision for Other Losses USD 55,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 2.57M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 911,463 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 911,463 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 55,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 3.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap RestrictedCash Restricted Cash USD 95,032 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 58,400 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -118.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 17.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap RevenueRemainingPerformanceObligationPercentage Revenue, Remaining Performance Obligation, Percentage pure 0.01 2016-01-01 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap Revenues Revenues USD 17.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap RoyaltyExpense Royalty Expense EUR 736,167 2026-04-10 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 75.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 350,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067658
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 34.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 4.44M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001213900-26-089188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 5.9 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0.2 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067658
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.8 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098409
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3,200 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 746,240 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 2.05M 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044163
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.31 2023-12-04 2024 Q2 10-Q 2024-08-12 0001213900-24-067658
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 49.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap StockholdersEquityOtherShares Stockholders' Equity, Other Shares shares 16,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap StockIssued1 Stock Issued USD 928,874 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 8.70M 2024-11-13 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 758,300 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001213900-26-056588
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 4.61M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 10,500 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067658
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.27M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 32.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 3.73M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001213900-26-037614
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 723,412 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067658
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 417,064 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 9.11 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076600
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax USD -4.19M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -3.16M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026225
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 6.60M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 16.09M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-110061
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 21.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 21.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118702

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →